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OBJECTIVES To explore whether the use of snuff affects the risk of myocardial infarction (MI).
BACKGROUND Snuff and other forms of smokeless tobacco are widely used in some populations. Possible
health hazards associated with the use of smokeless tobacco remain controversial.
METHODS In a population-based study within the framework of the Northern Sweden center of the
World Health Organization Multinational Monitoring of Trend and Determinants in
Cardiovascular Disease (WHO MONICA) Project, tobacco habits were compared in 25- to
64-year-old men with first-time fatal or nonfatal MI and referent subjects matched for age
and place of living (687 cases, 687 referents).
RESULTS The unadjusted odds ratio (OR) for MI in regular cigarette smokers as compared with men
who never used tobacco was 3.65 (95% confidence interval [CI] 2.67 to 4.99). When
nonsmoking regular snuff dippers were compared with never-users of tobacco, the unadjusted
OR was 0.96 (0.65 to 1.41). After adjustment for multiple cardiovascular risk factors, the OR
was 3.53 (95% CI 2.48 to 5.03) for regular smoking and 0.58 (95% CI 0.35 to 0.94) for
regular snuff dipping. Restricting the analyses to fatal cases of myocardial (including sudden
death) showed a tendency towards increased risk among snuff dippers 1.50 (95% CI 0.45 to
5.03).
CONCLUSIONS The risk of MI is not increased in snuff dippers. Nicotine is probably not an important
contributor to ischemic heart disease in smokers. A possible small or modest detrimental
effect of snuff dipping on the risk for sudden death could not be excluded in this study due
to a limited number of fatal cases. (J Am Coll Cardiol 1999;34:1784–90) © 1999 by the
American College of Cardiology
The cigarette smoking epidemic is worldwide. In contrast,
extensive use of snuff and other forms of smokeless tobacco
is largely restricted to certain geographical areas such as
North America, the Scandinavian countries (1), India,
Bangladesh and Southeast Asia (2,3). In the U.S., moist
snuff and cigars are now the only tobacco products with
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increasing sales (4–6). The prevalence of use of snuff and
other types of smokeless tobacco is particularly high in
several southern and southwestern states (5,7). Snuff is often
used in certain subsets of a population, such as athletes (8,9),
male adolescents and young adults (4,10,11). The Youth
Risk Behavior Survey has revealed that as many as a quarter
of white male students in the U.S. report regular use of
smokeless tobacco (12).
Acting on a World Health Organization (WHO) recom-
mendation to prevent snuff dipping in countries where oral
tobacco use is not yet established, the European Union has
prohibited the sales of snuff in its members states, Sweden
exempted (13). Cardiovascular health hazards associated
with the use of snuff and other types of smokeless tobacco
are, however, poorly documented. During a 12-year
follow-up of a cohort of Swedish construction workers,
those who used snuff at baseline had a 40% higher risk of
cardiovascular death compared with nontobacco users (14).
On the other hand, no excess risk for myocardial infarction
(MI) was noted in a Swedish study based on comparisons of
tobacco status between subjects with and without MI in a
population of middle-aged men (15).
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This study was initiated to resolve some of the contro-
versies surrounding the effects of snuff dipping on ischemic
heart disease. Detailed information on tobacco habits and
possible confounding factors was obtained in a population-
based series of patients with fatal and nonfatal acute MI and
compared with age-matched referent subjects without MI.
METHODS
This population-based study covered 25 to 64-year-old men
in the two northern-most counties in Sweden (target
population 139,215 in 1994), a population with a high
prevalence of snuff dipping (15) in a sparsely populated area
with nine acute-care hospitals. It was a substudy performed
within the Northern Sweden (Multinational Monitoring of
Trends and Determinants in Cardiovascular Disease)
(MONICA) Center, which is one of the 38 collaborating
centers in the WHO MONICA Project (16). The main
objective of this prospective project is to assess how changes
in the incidence of coronary heart disease and cerebrovas-
cular disease over a 10-year period relate to changes in
cardiovascular risk factors in the population (16).
All cases of acute myocardial infarction (AMI) and
sudden death, fatal and nonfatal, occurring in-hospital and
out-of-hospital were recorded from May 1, 1991 to Decem-
ber 31, 1993 in a standardized manner using the WHO
definitions and the MONICA methodology (17). Cases of
MI and sudden death were ascertained through screening of
hospital discharge records, general practitioners’ reports and
death certificates with international classification of diseases
(ICD) codes 410–414. This study was restricted to first-
ever events of AMI. The number of subjects with confirmed
or suspected MI not included in the Northern Sweden
MONICA register because of refusal after information has
been given averages of three per year (,0.5%).
Data collection in hospitalized patients included infor-
mation on medical history, symptoms, ECG and cardiac
enzymes. Patients in hospitals were visited by a MONICA
team nurse to obtain additional information, including data
on tobacco habits. In fatal cases, information from death
certificates and necropsy reports was used as supplementary
sources of information. In cases of sudden death, a family
member was asked to complete a questionnaire about social
conditions, risk factors, medical history and tobacco use.
Detailed data collection on tobacco habits included onset,
duration and amount of cigarette, cigarillo and cigar smok-
ing and moist snuff dipping (moist snuff is the only form of
smokeless tobacco used in northern Sweden). Six questions
concerned use of snuff (present use, previous use, amount of
snuff consumed, type of snuff preparation used, age at onset
of snuff use and a question on whether or not start of
snuffing was associated with quitting to smoke). The ques-
tion on which most of the analyses in this study was based
was, “Do you use snuff at present?” with three response
alternatives (yes daily, no, occasionally). A regular cigarette
smoker was defined as a person smoking one cigarette daily
or more, and a regular snuff dipper took snuff at least once
daily.
To validate the information on tobacco habits provided
by the spouse in fatal cases, 51 spouses of surviving patients
were interviewed by telephone two months after the hospi-
talization. There was a very good agreement between the
responses by the patients and their spouses concerning use
of snuff when the MI occurred (98% agreement) whereas
information was somewhat less reliable on former use of
snuff (92% agreement), age of onset of snuff use (82%
agreement) and whether or not the snuffing habit was taken
up upon quitting smoking (90% agreement).
Possible cases of AMI and sudden death were validated
using the MONICA criteria (17). Methods for classification
and diagnosis of MI and sudden death have been described
in detail elsewhere (18). In addition to the enzymes recom-
mended in the MONICA core study, namely creatinine
phosphokinase (CK), aspartate transaminase (ASAT) and
hydroxybutyric dehydrogenase (LD), LD-1 and CK-MB
were included in the Northern Sweden MONICA Study.
Acute myocardial infarction cases were classified into one
of the categories “definite infarction,” “possible infarction or
coronary death,” “ischemic cardiac arrest with successful
resuscitation not fulfilling criteria for definite or possible
myocardial infarction,” “unclassifiable infarction” or “not
infarction” (17). Unclassifiable events were mostly fatal cases
with a death certificate diagnosis of AMI where no infor-
mation on previous history of AMI or of the clinical event
was obtainable. In this article, only cases classified as
“definite infarction” have been included in nonfatal events.
In fatal events, “possible infarction” and “unclassifiable
infarction” have also been included in accordance with the
agreed convention in the core MONICA Project (17).
Subjects who died within 28 days from the onset of AMI
were recorded as fatal cases.
Consistency over time was ensured by regular centralized
quality controls (17) and the same personnel abstracting and
recording data throughout the study.
Referents (men without MI) were selected from contin-
uously updated population registers, matching for county of
residence and choosing the two individuals with the dates of
birth closest to the index patient (usually the same date of
birth). Informed consent was sought in a letter to the person
selected first. A telephone interview was then conducted (all
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interviews by the same observer) involving the same ques-
tions as those given to the patients, except that the AMI-
specific items were excluded. However, a history of AMI
was asked for; case-referent pairs in which the referent
reported a history of AMI were excluded from the analyses.
If the first control person did not respond or did not consent
(’20%), the second of the selected control men was
contacted.
To achieve a uniform mode of data collection, oral
interviews were not used for men who served as referents to
fatal cases. Instead, they received the same questionnaire as
that sent to the family members of deceased patients (cf.
above).
The total number of men with a documented first AMI
or sudden death was 879. In 95 case-referent pairs, neither
of the two selected control persons responded or the referent
had had an AMI. When information was obtained by
interview, the response rate was 96% (cases and referents
combined) and when it was obtained by a questionnaire the
response rate was 90%. Among the respondents, informa-
tion on tobacco habits was sometimes incomplete or miss-
ing. After exclusion of such case-referent pairs, 687 men
with AMI or sudden death and 687 matched control men
remained for analysis (78.2% of the eligible case-referent
pairs). Of the 687 cases, 117 were fatal within the first
28 days.
Partial data were available in 164 patients who were not
included and in 96 of the nonincluded referents. In com-
parison with the included patients, nonincluded patients
with AMI were less often married or cohabitant (68.9% vs.
79.2%, p 5 0.007 by Fisher’s exact test) and a higher
proportion had education above primary school (38.4% vs.
24.0%, p 5 0.003). A similar proportion of nonincluded
referents were married or cohabitant when compared with
referents who were included (82.3% vs. 86.9%, p 5 0.21),
and a similar proportion had education above primary
school (40.0% vs. 43.5%, p 5 0.39). The mean age did not
differ significantly between included and excluded subjects
(55.6 years in included case-referent pairs, 55.4 years in
excluded AMI patients and 57.3 years in excluded refer-
ents).
The 95% confidence intervals (CIs) were calculated ac-
cording to the binomial distribution for the number of
events within the age groups. Crude odds ratios (ORs) and
their 95% CIs were calculated using the CIA software (BMJ
Publishing Group, London, United Kingdom). Odds ratios,
adjusted for various cardiovascular risk factors, were calcu-
lated by means of conditional logistic regression. The
statistical package SPSS 7.5 was used for all calculations
except conditional logistic regression, for which Stata was
used (Stata Statistical Software: release 5.0, Stata Corpora-
tion, College Station, Texas).
The study was approved by the Ethical Committee at
Umeå University and the computerized patient database by
the National Computer Data Inspection Board.
RESULTS
The mean age was 55.6 years (95% CI 55.1 to 56.1 years)
both in the 687 men with first AMI or sudden death and in
their 687 age-matched referents. Regular smoking was
much more common among men with AMI than among
age-matched reference subjects (Table 1). The proportion
of ex-smokers was also higher in referents than in AMI
patients. As shown in Table 1, regular snuff dipping without
concomitant smoking was less common in AMI patients
than in referents (8.6% vs. 13.1%, p 5 0.009). A history of
previous regular use of snuff was more common in control
subjects (p 5 0.009). Among smokers, the median daily
consumption of cigarettes was 20 in cases and 15 in
referents. In snuff users, the median consumption was two
boxes per day in both cases and referents. Information on
duration of snuff use was found to be of inferior quality, in
particular in fatal cases, and was not analyzed further. The
median age at onset of use of snuff was as high as 31.5 years,
explained by the the fact that many had started to use snuff
in conjunction with quitting smoking (49% of snuffing cases
and 41% of snuffing referents).
Table 1. Univariate Comparisons of Tobacco Habits Between 25- to 64-Year-Old Male Patients





Never used tobacco 149 (21.7%) 217 (31.6%) 1.00
Current snuff user, no current smoking* 59 (8.6%) 90 (13.1%) 0.96 (0.65–1.41)
Current smoker, no current snuff use* 248 (36.1%) 99 (14.4%) 3.65 (2.67–4.99)
Current snuff user and smoker 20 (2.9%) 11 (1.6%) 2.66 (1.24–5.71)
Former snuff user, never smoked 11 (1.6%) 13 (1.9%) 1.23 (0.54–2.82)
Former smoker, never used snuff 129 (18.8%) 179 (26.0%) 1.05 (0.77–1.43)
Former smoker and former snuff user 37 (5.4%) 54 (7.9%) 0.99 (0.62–1.59)
Other combinations, unclassifiable 34 (4.9%) 24 (3.5%) –
Total 687 (100%) 687 (100%) –
*Excluding subjects who reported occasional smoking or occasional snuff dipping (less than once daily). Odds ratio for men who
never used tobacco 5 1.00.
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When subjects without a history of regular tobacco use
were used as reference, the OR for AMI associated with
regular smoking (and not using snuff) was 3.65 (2.67 to
4.99), whereas the OR associated with regular snuff dipping
(without smoking) was 0.96 (0.65 to 1.41).
The 117 fatal cases and their controls were analyzed
separately. These included men who died from a definite
(n 5 52) or suspected (n 5 54) MI, but also cases of sudden
death without any indication of a cause other than a cardiac
one (n 5 11). Regular tobacco smoking was four times as
common in fatal cases (53 men, 45%) compared with
reference subjects (13 men, 11%). On the other hand,
regular use of snuff among nonsmokers was very similar in
fatal cases and in referents (15 men, 13% vs. 14 men, 12%).
Former snuffing was recorded among nine AMI patients
(8%) and 11 referents (9%).
Patients with AMI differed from reference persons in
several aspects other than tobacco habits (Table 2). Thus,
patients were less often married or cohabitant, and a lower
proportion had education above primary school. Before the
first AMI, the patients had more often been informed about
high serum cholesterol levels and elevated blood pressure
than age-matched reference men. The patients also more
often had a history of diabetes, and a larger proportion had
a first-degree family member who had died from an MI
before the age of 65.
Conditional logistic regression models were used to
analyze the predictive value of various tobacco habits,
independent of confounding factors, on the risk for MI for
both all events and fatal events only. Separate regression
models were used for smoking and use of snuff. When all
AMI patients were analyzed together and snuff dippers were
excluded, smoking, hypertension, diabetes, high cholesterol,
a family history of early cardiac death, low level of education
and not being married or cohabitant all emerged as inde-
pendent determinants of AMI (data not shown). In a
corresponding model in which smokers were excluded, the
same predictors except for marital status were independent
predictors of MI. Snuff dipping however was not (Table 3,
left column). Neither was snuff use associated with AMI if
adjusted only for social variables (data not shown). After
adjustment for the risk factors listed above, the OR for all
Table 2. Univariate Comparisons of Basal Characteristics Between 35 to 64-Year-Old Male








Not married or cohabitant 143 (20.8%) 90 (13.1%) 1.74 (1.31–2.33)
Level of education*
Primary school 510 (74.2%) 377 (54.9%) 2.45 (1.94–3.09)†
Secondary school 97 (14.1%) 169 (24.6%)
University 68 (9.9%) 130 (18.9%)
First-degree family member(s)
Dying from heart disease
Before the age of 65
136 (19.8%) 94 (13.7%) 1.56 (1.17–2.08)
Previously diagnosed diseases
Blood pressure elevation 290 (42.2%) 182 (26.5%) 2.03 (1.61–2.54)
High cholesterol levels 228 (33.2%) 150 (21.8%) 1.78 (1.40–2.26)
Diabetes 79 (11.5%) 28 (4.1%) 3.06 (1.96–4.77)
*Information not available in 12 cases and 11 controls; †primary school vs. secondary school or university.
Table 3. Conditional Logistic Regression Analysis of Independent Predictors of AMI Excluding
Present Smokers: 658 Valid Observations in the Analysis of Fatal and Nonfatal Events
Combined and 106 Valid Observations in the Analysis of Fatal Events
Variable
Odds Ratios (95% CIs)
Fatal and Nonfatal
AMI Fatal AMI Only
Hypertension 1.89 (1.31–2.73) 1.47 (0.43–5.05)
Low level of education 2.01 (1.39–2.90) 1.87 (0.52–6.73)
Not married or cohabitant 1.56 (0.94–2.59) 7.60 (1.66–34.85)
Diabetes 2.41 (1.30–4.48) 1.63 (0.36–7.37)
Known high cholesterol 2.15 (1.42–3.24) 2.97 (0.91–9.67)
Heredity* 1.64 (1.01–2.66) 3.39 (0.94–12.25)
Regular use of snuff 0.58 (0.35–0.94) 1.50 (0.45–5.03)
*First degree family member who died from a myocardial infarction before the age of 65.
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cardiac events associated with smoking was 3.53 (95% CI
2.48 to 5.03), whereas that associated with snuff dipping was
0.58 (95% CI 0.35 to 0.94). An unconditional logistic
regression model with the matching variables included did
not produce results that were qualitatively different.
When the analyses were restricted to cases with fatal
outcome and their controls, the conditional logistic model,
not including snuff dippers, revealed regular smoking, hy-
pertension, heredity for AMI and marital status to be
independent predictors of cardiac (or sudden) death (data
not shown). In a model excluding smokers, the statistical
power was low and only marital status was a significant
predictor (Table 3, right column). Snuff dipping was not a
significant predictor. The OR of fatal AMIs and sudden
death, adjusted for multiple risk factors, associated with
smoking was 8.57 (95% CI 2.48 to 30.3) and with snuff
dipping 1.50 (0.45 to 5.03).
DISCUSSION
In this study, snuff dippers had no overall excess risk for MI,
fatal and nonfatal events taken together. A possible small
detrimental effect on the risk for sudden death could not be
excluded due to a limited number of fatal cases and, thus,
large CIs. In univariate and multivariate analyses, marital
status, level of education, heredity for AMI and several
pre-existing disorders were shown to increase the risk for
MI. This closely coincides with what is known about social
and biological risk factors for MI and indicates that the
present study design, patient sample and selection of
matched referents were valid.
Methodological aspects. Of the original set of case-
control pairs, 21.8% were excluded in the analyses, often
because data on tobacco habits were missing in one or both
subjects. This was particularly common in pairs with a fatal
case (in 60 out of 190 pairs). The proportion that was
married or cohabitant was lower among excluded AMI
patients than among the included patients, whereas a higher
proportion of excluded patients had education above the
primary school level. These differences in social background
tend to counterbalance each other. When included and
excluded reference men were compared, there were no
important differences in marital status or level of education.
In a fifth of the case-control pairs, the first selected control
person did not respond and was replaced by a second control
man. Since tobacco use is usually more common among
nonresponders (19), this may have reduced the prevalence of
tobacco consumers in the control group somewhat. If
anything, it would have resulted in an even smaller likeli-
hood for snuff being linked to an enhanced risk of AMI.
Information on alcohol use was not collected in this study.
Since regular intake of alcohol is associated with a decreased
risk of AMI, a confounder effect may be present if the
alcohol consumption pattern in snuff dippers is different
from that in nonusers of tobacco.
No increased risk of AMI. The present results agree very
closely with a previous smaller study performed within the
framework of The Northern Sweden MONICA Project
using nonmatched group comparisons (15). In that study, in
which patient or control subjects did not overlap with the
present matched case-referent study, we failed to show that
snuff dipping was associated with an excess risk of MI in
univariate as well as multivariate analyses. The results of our
two studies should be compared with observations by
Bolinder et al. (14) in a large cohort study involving 135,000
male construction workers who were followed for 12 years
after their tobacco habits had been mapped in the early
1970s. A 40% excess risk for cardiovascular death was
observed among snuff dippers. It should be emphasized that
the present results, although not showing any increased risk
for MI, do not exclude a possible small excess risk of
cardiovascular death among snuff dippers. Nicotine has
immediate effects on the heart rate (20) and the possibility
that snuff is arythmogenic cannot be excluded. A change in
the composition of moist snuff from the 1970s to the 1990s
with a reduced content of tobacco-specific nitrosamines (21)
may also have modified health hazards resulting from the
use of snuff.
Smoking versus snuffing—possible mechanisms. The
great difference in risk for MI between cigarette smoking
and snuff dipping observed in this study provides important
information in how the effects of smoking on cardiovascular
risk are mediated. Some of the components of tobacco
smoke are produced when tobacco is heated and burned
(22). Other tobacco components are better absorbed
through airways than through the buccal mucosa. However,
it should be noted that tobacco-specific nitrosamines can be
absorbed from snuff to a considerable extent (23,24). The
first demonstration has recently been made of a single
cigarette smoke component (1,3 butadiene) that accelerates
atherosclerotic plaque development (25).
Other components differ only slightly between smoking
and oral tobacco. The most important of these is nicotine.
Even if the nicotine content is lower in Swedish than in
American snuff (26), plasma levels of nicotine are as high in
Swedish snuff dippers as they are in smokers (27). It appears
from our data that nicotine is not an important contributor
to MI (and probably not to atherothrombotic mechanisms
in general). It is more likely that moieties specific to tobacco
smoke mediate the excess risk. Among the about 2,500
chemical substances identified in tobacco smoke, tobacco-
specific nitrosamines and polycyclic aromatic hydrocarbons
are some of the candidates as etiological agents for cardio-
vascular disease (24,28,29).
It is controversial whether there are any chronic hemo-
dynamic effects of snuff dipping. In the study of Swedish
construction workers performed in the 1970s, snuff dippers
had a higher prevalence of elevated blood pressure levels
than nontobacco users (30). Differences in resting blood
pressure levels between snuff dippers and nontobacco users
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have not been possible to confirm in more recent studies,
including a population-based sample of 25- to 64-year-old
people in Sweden (31), a study on Swedish male students
(32) and an investigation among snuff-dipping baseball
players in the U.S. (8).
The present results from Sweden cannot be extrapolated
to other countries without caution. A major part of tobacco
used in Sweden is now prepared without traditional smoke-
drying and this reduces the content of polycyclic aromatic
hydrocarbons markedly (33). Whereas Swedish snuff is
prepared by a heating process, yielding a semisterile product
(21), U.S. snuff is produced by fermentation (10,26). Al-
though the content of tobacco-specific nitrosamines was
reduced markedly in U.S. snuff during the 1980s, the
concentrations were still twice as high as in Swedish snuff
(26). In other countries, like Sudan, snuff may contain
exceedingly high concentrations of tobacco-specific nitro-
samines (23). Even within the same country, there are wide
variations in the content of nicotine and carcinogenic
tobacco-specific nitrosamines between different brands of
moist snuff (10,26).
A complicated message. The present observations would
show that, from a cardiovascular perspective, the deleterious
effects of snuff dipping are much less than those of cigarette
smoking. This is a complicated message. Faced with anti-
smoking campaigns and restrictions on sales of cigarettes, it
is tempting for the tobacco industry to turn to less contro-
versial alternatives, i.e. various forms of smokeless tobacco.
In the U.S., the Smokeless Tobacco Council contributes
considerably to the total lobbying by the tobacco industry
(34). The increased sales of smokeless tobacco in countries
like the U.S. and Sweden during recent years is, at least
partly, the result of a determined effort by the industry to
promote consumption. It must be emphasized that there is
often a heavy addiction to nicotine among snuff dippers, and
the success rate among people who try to quit using snuff is
no better than that among cigarette smokers (35). Further-
more, an excess risk of oral cancer has been observed in snuff
users (3,28). From a medical point of view, the only
reasonable norm is nonuse of tobacco.
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